Indian Vaccines Corporation Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 18.79 Cr
as on 17-11-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -17.40%
(FY 2023)
- Profit 142.54%
(FY 2023)
- Ebitda -10.17%
(FY 2023)
- Net Worth 34.62%
(FY 2023)
- Total Assets -14.33%
(FY 2023)
About Indian Vaccines Corporation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 18.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indian Vaccines Corporation Limited India is Ajay Kumar as COMPANY SECRETARY. Shrivallabh Goyal, Sudhir Jain, Pankaj Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74900HR1989GOI030516
- Company No.
030516
- Company Classification
Public Limited Union Government Company
- Incorporation Date
27 Mar 1989
- Date of AGM
08 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationGurgaon, Haryana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indian Vaccines Corporation?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Kumar | Company Secretary | 09-May-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Misra  | Director | 17-Sep-2021 | Current |
| Shrivallabh Goyal | Director | 30-Jul-2009 | Current |
| Sudhir Jain | Nominee Director | 31-Dec-2014 | Current |
| Pankaj Kumar | Nominee Director | 28-Oct-2021 | Current |
| Alka Sharma | Nominee Director | 23-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Indian Vaccines Corporation.
Indian Vaccines Corporation Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.4% decrease. The company also saw a substantial improvement in profitability, with a 142.54% increase in profit. The company's net worth Soared by an impressive increase of 34.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Vaccines Corporation?
In 2023, Indian Vaccines Corporation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indospace Met Logistics Park Farukhnagar Private LimitedActive 4 years 5 monthsShrivallabh Goyal is a mutual person
Bharat Immunologicals And Biologicals Corporation LimitedActive 35 years 9 monthsPankaj Kumar and Alka Sharma are mutual person
Model Economic Township LimitedActive 18 years 2 monthsShrivallabh Goyal and Sudhir Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indian Vaccines Corporation?
Unlock and access historical data on people associated with Indian Vaccines Corporation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Vaccines Corporation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Vaccines Corporation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
